We have detected a disorder in Korat cats (initially imported from Thailand) that is analogous to human Sandhoff's disease. Pedigree analysis indicates that this disease in an autosomal recessive disorder in the American Korat. Postmortem studies on one affected cat showed hepatomegaly that was not reported in the only other known feline model of GM2-gangliosidosis type II. Histologic and ultra-structural evaluation revealed typical storage vacuoles. There was a marked deficiency in the activity of hexosaminidase (HEX) A and B in affected brain and liver as compared to controls. Electrophoresis of a liver extract revealed a deficiency of normal HEX A and B in the affected animals. The blocking primary enzyme immunoassay verified the presence of antigenically reactive HEX present in affected cat livers in quantities slightly elevated with respect to the normal HEX concentration in control cats. In leukocytes, obligate heterozygotes had intermediate levels of total HEX activity with a slight increase in the percent activity due to HEX A. Indeed, 4 of 11 phenotypically normal animals in addition to four obligate heterozygotes appear to be carriers using this assay. Affected brain and liver compared with control brain and liver contained a great excess of bound N-acetylneuraminic acid in the Folch upper-phase solids; thin-layer chromatography showed a marked increase in GM2-ganglioside. In summary, we have characterized the pedigree, pathology, and biochemistry of a new feline model of GM2-gangliosidosis which is similar to but different from the only other known feline model.
Introduction
The study of lysosomal storage diseases, particularly the gangliosidoses, has been facilitated by the use of animal models. Unfortunately, well-characterized animal models are rare, and are consequently difficult to obtain for research. One of the established animal models is the feline model for human GM2-gangliosidosis, characterized and maintained in very limited numbers (1) (2) (3) . These domestic cats have a deficiency of hexosaminidase (HEX)' A and B activity, the equivalent to Sandhoff's disease in humans.
We report here the characterization of a new feline model of Sandhoffs disease, which is similar to, yet different from the previously existing model (1, 2) . Affected cats manifest the clinical symptoms of Sandhoffs disease including clinically apparent hepatomegaly, a finding never before reported in any animal gangliosidosis model (3) . Affected animals have a marked deficiency in the activity of HEX A and B. These highly inbred Korat cats were originally imported from Thailand in 1959, and detailed genetic information is available. Carriers have intermediate levels of enzyme activity as expected with an autosomal recessive disorder.
Using the primary enzyme immunoassay (PEIA), a primary binding test which requires neither monospecific antibody nor purified enzyme, we have detected the existence of enzymatically inactive, antigenically cross-reactive HEX (4, 5) . Thus, this animal model results from a structural gene defect that is highly analogous to the human disorder (6) .
Methods
Animals. The index case (see pedigree, Fig. 1 ) was a female Korat kitten with progressive neurologic dysfunction. The kitten was placed in our laboratory for evaluation of a suspected genetic disorder, possibly a gangliosidosis, which had been previously observed clinically by Korat breeders. A subsequent litter of kittens was bred and the litter yielded two additional affected animals, a male and a female. Other informative cats are in the custody of their owners, who have kindly provided us with blood samples and information, for which we are grateful. Normal unrelated domestic kittens of comparable age and size were obtained for controls.
Kitten 1, the index case, was killed humanely at 30 wk by barbituate overdose. Tissue biopsies from liver, brain, spleen, kidney, dorsal root ganglia, and skeletal muscle were retained and fixed for pathology. Skin samples were taken and fibroblasts were cultured and frozen for future use. Remaining tissues were frozen at -70'C for subsequent enzymatic analysis. Tissues from two more affected animals have been frozen at -70'C for analysis. Three unrelated normal random source kittens of comparable size and age were killed humanely by barbituate overdose, and the tissues were processed similarly to the first diseased kitten, to be used as control samples.
Pathology. The first affected kitten was anesthetized with 1 ml/kg of a ketamine/xylazine mixture (100 mg/20 mg per ml) and placed on a Harvard, Model 686, small animal respirator. Biopsies of brain and liver were obtained, immediately fixed in mixed aldehydes for electron microscopy, and stained with periodic acid-Schiff (PAS) for frozen section light microscopy. After euthanasia, tissue samples, which included brain, liver, spleen, lung, skeletal muscle, sciatic nerve, dorsal root ganglia, and eye, were removed and fixed in formalin. Tissues selected for light microscopy were paraffin embedded, sectioned, and stained with toluidine blue, hematoxylin and eosin, PAS, and luxol fast blue. Detailed histologic evaluation was carried out at the light microscopic level.
Tissues to be examined ultrastructurally were postfixed in 2% osmium tetraoxide, dehydrated in ascending concentrations of ethanol, and embedded in Epon 812. Sections were cut with a diamond knife, mounted on bare copper grids, and stained with uranyl acetate and lead citrate.
Preparation of blood leukocyte extracts. Leukocytes were prepared from heparinized whole blood by the method of Kaback et al. (7) .
Erythrocytes were sedimented with dextran (M, of 250,000 from Sigma Chemical Co., St. Louis, MO), and the leukocyte-rich supernatant was centrifuged at 645 g for 5 min to form a leukocyte pellet. Leukocytes were resuspended in water for 30 s to lyse red cells, and then NaCI was added to a final concentration of 0.9% and the cells again centrifuged. The cells were resuspended in water and sonicated before enzyme analysis.
Preparation of tissue samples for enzyme assays. Tissue samples (brain and liver from affected and control animals) were prepared for enzyme assays by homogenization at 4VC in 5 vol of 0.25 M sucrose, 5 mM Tris, I mM EDTA, pH 7.5, with 0.1% Triton X-100. Samples were then centrifuged at 4VC, 10,000 g for 30 min. The supernatants were removed and retained on ice for enzyme analysis.
a-HEX assay. Leukocytes and tissue extracts were analyzed for total #-HEX activity with 2.5 mM 4-methylumbelliferyl-,-D-N-acetylglucosaminide (4MU-ft-GlcNAc), from Sigma Chemical Co., as the final substrate concentration. Analysis was carried out using a modification of the method of Kaback et al. (8) . Substrate hydrolysis was measured spectrophotometrically at 360 nm with a Hitachi-PerkinElmer double beam spectrophotometer and specific activity was reported as nmoles per milligram protein per hour. Percentages of total #-HEX activity due to heat labile and heat stabile fractions were determined by preincubation of the enzyme extract at 50°C for 2 h.
Lysosomal enzyme assays. Brain samples were analyzed forgalactosidase, arylsulfatase-A, and a-L-N-acetylneuraminidase by methods outlined by Galjaard et al. (9) (12) . Standard enzyme-mediated dissociation of the blocking enzyme was evaluated by reversing the order of enzyme addition to the reaction mixtures. For comparison with this assay, immunodiffusion studies were also performed in accordance with the methods of Ouchterlony (13) .
Pedigree analysis. A pedigree for the Korat cat family was constructed based on information supplied by the various breeders of the cats involved. The coefficient of inbreeding for the parents of the proband was estimated by the method originally developed by Wright (14) as outlined by Levitan and Montagu (15) .
Lipid analysis
Preparation of Folch upper-phase and lower-phase lipids from brain and liver of affected and control cats. Tissues were weighed and homogenized with 19 vol of chloroform/methanol (2:1). After suction filtration through washed filter paper, the filter cakes were rehomogenized with 10 vol of chloroform/methanol (1:2). After filtering again, the filtrates were combined and 10 vol of chloroform added. The modified Folch partition (16, 17) was performed in a separatory funnel by adding 0.2 vol (eight original volumes) of 0.88% aqueous KCI solution. The funnel was shaken vigorously 200 times and let stand overnight. Phases were separated and measured, and the lower phase washed twice with theoretical-upper-phase KCI (chloroform/methanol/0.75% aqueous KC (2:48:47)) and once more with theoretical-upper-phase water. The upper phases were combined and solvents removed under vacuum.
The aqueous solution was dialyzed against 100 vol X 3. of distilled water at 40C, centrifuged, Iyophylized, and stored at -70'C. NAcetylneuraminic acid content was determined by the method of Aminoff (18).
Sephadex G-100 was added to the lower phase to remove water (19) . The filtered lower phase was taken to dryness under vacuum; absolute ethanol was added twice to dryness under the vacuum; the dry lower-phase lipids were kept at -20'C and dissolved in chloroform/ methanol (1:1) for spotting on thin-layer plates.
Thin-layer chromatography. Thin-layer chromatography was performed on 20 X 20-cm silica gel 60 high performance thin-layer plates (A.H. Thomas Co., Philadelphia, PA) that had been activated at 1 10C for I h. The concentration zone on these plates was not used; plates were run with this zone at the top, having been spotted 2 cm up from the lower margin. Upper-phase solids were spotted from water, lower phase from chloroform/methanol (1:1). Plates were developed (20) ascending (in chambers equilibrated with blotting paper) to 18 cm from the bottom. Plates of lower-phase lipids were sprayed with orcinol to detect carbohydrate-containing spots and (on separate plates) with resorcinol spray reagents to identify bands containing sialic acid (19) .
Results
Clinical presentation. Korat Pedigree analysis. The pedigree constructed for the Korat cat family under investigation is consistent with an autosomal recessive mode of inheritance for GM2-gangliosidosis (Fig. 1) . Evidence which supports this hypothesis is that both sexes are affected, parents are phenotypically normal, siblings are frequently affected, there is parental consanguinity, and there is disease recurrence in the inbred population after many skipped generations.
An estimate of the coefficient of inbreeding (F) for the parents of the proband concluded that these individuals have -59% of their genes in common, which indicated that they are genetically more closely related than full siblings.
Pathology. Postmortem examination of various tissues from the initial 7-mo-old affected kitten displayed the histopathologic consequences of advanced S-HEX deficiency. His (Table I ). There was no detectable activity in brain tissue from kitten 1, which was 3 mo older and more severely
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Thailand (1974) affected than kitten 2, which had 14% of normal activity. Affected liver, which normally expresses a high level of HEX activity, had from 4 to 6% of the activity seen in the normal controls. The small amount of residual activity seen may be due to HEX S, a HEX alpha subunit homopolymer seen in human Sandhoff fibroblasts as reported by Proia et al. (21) , or HEX C, an unrelated enzyme.
Characterizations of the PEIA. The experimental and control curves for the PEIA are shown in Fig. 4 . Experimental curves A and C, which correspond to control cat and human enzyme, respectively, did not produce the expected upper plateau region at high concentrations of the blocking enzyme, indicating the dissociation of some of the blocking enzyme bound in the first incubation from its immune complex into the final incubation mixture. Control curves B and D represented the evaluation of this possibility by the addition of buffer to the second incubation rather than the standard enzyme mixture. In this situation, any activity remaining in the final supernatant must have been due to blocking enzyme activity. The control lines B and D could then be subtracted from the experimental lines A and C, respectively, to present an approximate true value blocking curve.
One explanation for the reduced activity in the supernatant for the affected cat liver assay (line E) was reduced binding of the affected cat enzyme by antibody. An alternative explanation for this decreased supernatant HEX activity curve with affected cat liver enzyme other than reduced binding has been proposed. The possibility exists that free standard enzyme in the final reaction mixture is in rapid equilibrium with the bound blocking enzyme, thereby inducing the release of the blocking enzyme from antibody. With enzymatically active enzyme, this possibility was inconsequential due to the fact that a onefor-one exchange of active standard enzyme for active blocking enzyme would have no net effect. However, when the blocking enzyme has no enzymatic activity, this possibility takes on more significance. To evaluate this possibility, curve F was derived by reversing the order of the assay by adding the standard (normal human) enzyme to the first incubation mixture, and the blocking enzyme from a Sandhoff animal to the second incubation mixture. Had this alternative explanation been true, the expectation would have been release of a significant amount of active (human) enzyme into the supernatant. This did not occur. As a result of this control, it was concluded that it is the reduced binding of the affected cat enzyme protein that is responsible for this reduced curve (line E, Fig. 4 ).
The PEIA was also able to reveal quantitative results about the test enzymes, even though those enzymes may not be subject to direct assays, such as in the case of an inactive enzyme. Since the midpoints between the plateaus of each curve represented the quantity of blocking enzyme that occupies 50% of its antigen binding sites, the relative enzyme protein of each blocking solution could be evaluated by drawing a perpendicular line from this point to the relative enzyme protein axis (dotted lines, Fig. 4) .
Results ofthe PEIA. A reaction of identity may be defined Blocking Enzyme (Re Figure 4 . Use of the PEIA to compare the antigenicity of affected cat liver HEX (curve E) with control cat liver and human placental enzyme (curves C minus D and A minus B, respectively). Curves A minus B and C minus D are the experimental blocking curves, and A and C are corrected for blocking enzyme-antibody dissociation quantitated in curves B and D, respectively. Curve F is an additional control discussed in the text. The dashed lines correspond to the point at which 50% of the blocking enzyme is bound to antibody and was used to quantify the relative amounts of blocking enzyme presequivalent amount of crude human placental enzyme and crude human liver enzyme, a precipitin line did develop.
Determination ofcarrier state. 18 Korat cats were evaluated for HEX activities in leukocytes in an attempt to determine carrier status. Four normal domestic cats had leukocyte enzyme levels of 1,739±197 (SD) nmol/mg protein per h (Fig. 5) (Table II) . High performance thin-layer chromatographic (HPTLC) analysis of the upper-phase solids (Fig. 6) showed a striking increase of GM2-ganglioside. In liver, bound NAN content was 6.6-fold (cat 1) and 3.9-fold (cat 2) increased in upper-phase solids of the affected cats compared with control cat (Table II) . By HPTLC, this increase was accounted for in both brain and liver by strikingly increased GM2-ganglioside. However, gangliosides as yet unidentified, most Figure 5 . Determination of leukocyte HEX activity for examination of the carrier state. Domestic (n = 4) and Korat (n = 18) cats were evaluated for total HEX activity. Leukocytes were suspended and sonicated in water for analysis after centrifugation (645 g for 5 min) from separated whole blood with dextran. Activity is expressed as nanomoles substrate cleaved per milligrams protein per hour. All groups except obligate and probable carrier Korats were significantly different (P < 0.005).
with mobilities between those of GMl-and GM2-gangliosides, were also strikingly increased in liver of the affected cat compared with the normal. These unidentified gangliosides were not seen in normal or abnormal cat brain or normal human brain (Fig. 7) . Presumably these unidentified ganglio- and GMlb-GalNAc (IV4GalNAc, IV3NeuAc-GgOse4Cer).
Lower-phase lipids were also abnormal (Fig. 7) . Cat brain contained a single orcinol-positive species, migrating as GL-3, present in striking excess in affected brain compared with normal brain and presumed to be gangliotriaosylceramide. In the liver of the affected cat compared with control liver, a similar but smaller excess of presumed gangliotriaosylceramide was found. However, a striking and much greater excess was found of an orcinol-positive lipid, which migrated with globotetraosylceramide and was presumed to be globotetraosylceramide. The small amount of orcinol-positive and resorcinolpositive material near the origin found in both affected brain and liver but not control brain and liver appeared to be unextracted GM2-ganglioside.
Strikingly increased brain GM2-ganglioside and gangliotriaosylceramide with increases in liver of globotetraosylceramide and to a lesser extent gangliotriaosylceramide were findings quite compatible with Sandhoff disease in humans. The unusual feature in the affected cats was the additional presence in liver of large amounts of unidentified gangliosides, which may be a special feature of this feline model. A large excess of at least two abnormal oligosaccharides was found by HPTLC (23) in water extracts of affected cat liver, spleen, kidney, and heart; these were not seen in water extracts of control cat liver (data not shown).
Discussion
The usefulness of animal models of the GM2-gangliosidoses is well recognized. The PEIA has been used in this study to characterize the inactive affected cat enzyme protein. The advantages of this assay are its specificity and the fact that it eliminates the necessity of the monospecific antibody and/or pure antigen required for most immunoassays. Indeed, the only requirement for this system is the availability of a substrate.that is specific for the activity of the standard enzyme. The PEIA is highly sensitive in its ability to differentiate mutant enzymes from the same species (4, 5) . In this study, immunodiffusion studies on Ouchterlony plates were unable to reveal the existence of any cross-reactive material from either normal or affected cat liver, let alone differentiate between the normal and mutant cat enzyme, even though normal human placental and liver HEX A resulted in very definite precipitin lines which formed a line of identity.
We were also able to demonstrate a distinct separation between normal Korats and obligate heterozygotes. These findings concur with other feline models such as the GM, model reported by Baker (3) and GM2-gangliosidosis model by Cork (1) . Breeding among the suspected heterozygotes will indicate whether or not we can successfully identify carriers of the disorder and predict matings which will result in affected offspring.
The discovery and characterization of this model affords the opportunity to investigate the pathogenesis of lysosomal storage diseases, and to examine the efficacy of potential therapeutic trials, in particular the approaches to enzyme replacement therapy, or gene therapy. Numerous investigators have demonstrated that intravenous administration of active ,8-HEX A clears stored gangliosides from the serum and is taken up by the liver in patients with Tay-Sachs disease (GM2-gangliosidosis type I) (25) . Intrathecal injections of enzyme result in similar clearance of serum gangliosides (26) . No clinical trials, however, have been successful at transporting active enzyme across the blood-brain barrier (BBB) to the central nervous system (CNS), where its activity is most critical. Consequently, there is no clinical improvement in patients who have received therapeutic enzyme.
Several approaches to reversible opening of the BBB have been established with varying degrees of success. Osmotic BBB disruption has proven to be one of the safest and most useful methods of reversible BBB modification to date (27) . It is successfully used in clinical chemotherapeutic trials for malignancies of the CNS (28) and is being evaluated for use in the treatment of CNS infections (29) . It has been demonstrated in rats that active HEX A can be delivered to the cerebrum after osmotic disruption of the BBB, and that the enzyme is taken up by subcellular organelles presumed to be lysosomes (30, 31) . Uptake of HEX by brain cells may be a receptor-mediated event, which suggests that the process could be facilitated if the enzyme is recognized by the receptor (32) (33) (34) . The potential for amelioration of stored substrate in the CNS is supported by studies that have shown degradation of accumulated substrate in systemic organs after intravenous enzyme infusion in another feline model of GM2-gangliosidosis (24) . These studies indicate a potential for beneficial enzyme replacement therapy in conditions that require enzyme delivery to the CNS. The model reported here could be used to evaluate such therapy. 
